SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001225208-19-014015
Filing Date
2019-11-01
Accepted
2019-11-01 17:07:23
Documents
1
Period of Report
2019-10-30

Document Format Files

Seq Description Document Type Size
1 doc4.html 4  
1 doc4.xml 4 7721
  Complete submission text file 0001225208-19-014015.txt   9194
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Issuer) CIK: 0000310158 (see all company filings)

IRS No.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address
Nally Michael (Reporting) CIK: 0001763945 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-06571 | Film No.: 191187541